OpenUCT
metadata only
Development of novel bioanalytical assays and an objective adherence measure of key second-line tuberculosis drugs
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment#855887
- Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB#889808
- Treatment Shortening of MDR-TB Using Existing and New Drugs#834637
- Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines#125921
- Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis#813014
Record · ID 666629
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive